article thumbnail

Webinar: Bring successful protein degraders to the clinic

Drug Discovery World

A new webinar ‘ Selective degradation of cancer target WDR5 — Evaluation of PROTACs binary and ternary affinities with Spectral Shift ‘, brought to you by NanoTemper, is now available to watch on-demand.

article thumbnail

Selective degradation of cancer target WDR5 — Evaluation of PROTACs binary and ternary affinities with Spectral Shift

Drug Discovery World

These targets present challenges in the biophysical characterisation of binary and ternary complexes, making developing effective degraders complicated.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Listicle: Maximising outsourcing models beyond time and cost

Drug Discovery World

Challenges in outsourcing drug discovery. The goal of drug discovery is clear: Identify the most promising leads in the shortest amount of time. Alternatively, some targets require novel, innovative solutions that may not be accessible in conventional drug discovery labs. Opportunities, options, and outsourcing.

article thumbnail

AI At The Frontier: Empowering Early Career Professionals In Drug Discovery

Elrig

Webinar | Ai At The Frontier: Empowering Early Career Professionals In Drug Discovery WEBINAR – ARE YOU CURIOUS ABOUT THE CUTTING-EDGE INTERSECTION OF ARTIFICIAL INTELLIGENCE AND DRUG DISCOVERY? Are you curious about the cutting-edge intersection of Artificial Intelligence and Drug Discovery?

article thumbnail

Early phase support for plasmid DNA supply to secure future manufacturing

Drug Discovery World

Once leads are identified, Catalent’s cell line, process, and quality control assay development services will help ensure the plasmids meet the target critical quality attributes. The post Early phase support for plasmid DNA supply to secure future manufacturing appeared first on Drug Discovery World (DDW).

DNA 130